Table 2 Characteristics of survey respondents
Average age (years) | n = 121 | SD |
| Â | 59.6 | 11.1 |
Country of Birth | n = 121 | % |
 Australia (2 ATSIa) | 92 | 76.0 |
 New Zealand (2 Maori, 2 Samoan) | 6 | 5.0 |
 Europe / United Kingdom | 17 | 14.0 |
 Africa | 3 | 2.5 |
 Asia | 3 | 2.5 |
Languages spoken at home | n = 120 | % |
 English | 116 | 96.7 |
 English and another language | 4 | 3.3 |
Median years since diagnosis | n = 121 | range |
|  | 3.6 | 0.3–36.5 |
Diagnosis | n = 121 | % |
 Breast or gynaecological cancer | 82 | 67.8 |
 Haematological, bowel, skin or lung cancer | 25 | 20.7 |
 Prostate cancer | 4 | 3.3 |
 Other (includes multiple primary cancers) | 10 | 8.3 |
Current treatment | n = 121 | % |
 No treatment | 65 | 53.7 |
 Long-term treatment / rehabilitation | 46 | 38.0 |
 Active treatment | 10 | 8.3 |
Treatment in last 12 monthsb | n = 120 | % |
 None | 50 | 41.6 |
 Surgery | 38 | 31.6 |
 Radiotherapy | 31 | 25.8 |
 Chemotherapy | 26 | 21.6 |
 Other cancer medication | 25 | 20.8 |